SCHEMBL4852266

SCHEMBL4852266

c1ccc(COc2nn(-c3ccccc3)cc2CCc2cscn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 2/20 0.38
ADORA1 P30542 1/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
USP2 O75604 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SCN9A Q15858 4/20 0.36
KCNH2 Q12809 3/20 0.36
SCN5A Q14524 3/20 0.36
PTGS1 P23219 4/20 0.35
PTGS2 P35354 4/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
CNR1 P21554 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4848575 0.79 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL4847074 0.79 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTADORA1HPGD
SCHEMBL4846871 0.74 PTGS1 (0.41) ALDH1A1ADORA1HPGDNPSR1PTGS1
SCHEMBL4846922 0.74 PTGS1 (0.41) ALDH1A1ADORA1HPGDNPSR1PTGS1
SCHEMBL4846858 0.74 PTGS1 (0.41) ALDH1A1ADORA1HPGDNPSR1PTGS1
SCHEMBL5407280 0.73 ATP4A (0.42) ALDH1A1KDM4EMAPTADORA1HPGD
SCHEMBL5406901 0.73 KDM4E (0.57) ALDH1A1KDM4EMAPTADORA1HPGD
SCHEMBL5403139 0.70 CYP4F2 (0.48) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL5395054 0.70 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTADORA1HPGD
SCHEMBL716851 0.67 PTGS2 (0.52) ALDH1A1KDM4EADORA1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368578-B2 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-06 US disclosed
US-20060135578-A1 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-22 US disclosed
EP-1541564-A1 FIVE-MEMBERED HETEROCYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135578-A1 Five-membered heterocyclic compounds GPR119, OR10J3, CYP11B1 ALDH1A1 821/4885KDM4E 719/4885MAPT 4700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.